Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Oh

Showing results (341-350 of 374) with videos related to

Pageof 38
Sort By:
European Review for Medical and Pharmacological Sciences|September 11, 2012
Anti-inflammatory effects of Hylomecon hylomeconoides in RAW 264.7 cellsH S Chae, O H Kang, J H Keum, et al.
British Journal of Cancer|May 3, 2007
A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancerS C Oh, H Y Sur, H J Sung, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 8, 2013
Development and plasticity of outer retinal circuitry following genetic removal of horizontal cellsPatrick W Keeley, Gabriel Luna, Robert N Fariss, et al.
Neuro-Oncology|July 27, 2013
Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cellsMatthew Z Sun, Joseph M Kim, Michael C Oh, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2020
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 studyE Van Cutsem, K Muro, D Cunningham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2012
Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatmentJ Kwun, B C Oh, A C Gibby, et al.
European Review for Medical and Pharmacological Sciences|October 11, 2012
Anti-inflammatory effect of sinomenine by inhibition of pro-inflammatory mediators in PMA plus A23187-stimulated HMC-1 CellsY C Oh, O H Kang, S B Kim, et al.
European Review for Medical and Pharmacological Sciences|September 8, 2012
Antibacterial activity of bark of Alnus pendula against methicillin-resistant Staphylococcus aureusJ G Choi, M W Lee, S E Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2016
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinomaS-E Al-Batran, E Van Cutsem, S C Oh, et al.
Nature Communications|July 7, 2025
Early detection of emerging SARS-CoV-2 Variants from wastewater through genome sequencing and machine learningXiaowei Zhuang, Van Vo, Michael A Moshi, et al.
Pageof 38

Showing results (341-350 of 374) with videos related to

Sort By:
Pageof 38
European Review for Medical and Pharmacological Sciences|September 11, 2012
Anti-inflammatory effects of Hylomecon hylomeconoides in RAW 264.7 cellsH S Chae, O H Kang, J H Keum, et al.
British Journal of Cancer|May 3, 2007
A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancerS C Oh, H Y Sur, H J Sung, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 8, 2013
Development and plasticity of outer retinal circuitry following genetic removal of horizontal cellsPatrick W Keeley, Gabriel Luna, Robert N Fariss, et al.
Neuro-Oncology|July 27, 2013
Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cellsMatthew Z Sun, Joseph M Kim, Michael C Oh, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2020
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 studyE Van Cutsem, K Muro, D Cunningham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2012
Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatmentJ Kwun, B C Oh, A C Gibby, et al.
European Review for Medical and Pharmacological Sciences|October 11, 2012
Anti-inflammatory effect of sinomenine by inhibition of pro-inflammatory mediators in PMA plus A23187-stimulated HMC-1 CellsY C Oh, O H Kang, S B Kim, et al.
European Review for Medical and Pharmacological Sciences|September 8, 2012
Antibacterial activity of bark of Alnus pendula against methicillin-resistant Staphylococcus aureusJ G Choi, M W Lee, S E Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2016
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinomaS-E Al-Batran, E Van Cutsem, S C Oh, et al.
Nature Communications|July 7, 2025
Early detection of emerging SARS-CoV-2 Variants from wastewater through genome sequencing and machine learningXiaowei Zhuang, Van Vo, Michael A Moshi, et al.
Pageof 38